| scholarly article | Q13442814 |
| P2093 | author name string | Bänsch D | |
| Block M | |||
| Borggrefe M | |||
| Breithardt G | |||
| Brunn J | |||
| Castrucci M | |||
| Gietzen F | |||
| Weber M | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Effect of Antiarrhythmic Drug Therapy on the Incidence of Shocks in Patients who Receive an Implantable Cardioverter Defibrillator after a Single Episode of Sustained Ventricular Tachycardia/Fibrillation | Q33154641 | ||
| Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators | Q33156418 | ||
| Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks | Q33157498 | ||
| Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions | Q33174152 | ||
| Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator | Q33174543 | ||
| Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of P | Q33174830 | ||
| Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings | Q34274971 | ||
| Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest | Q36816260 | ||
| Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator | Q40741733 | ||
| Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy | Q44367719 | ||
| The minimally appropriate electrophysiologic study for the initial assessment of patients with documented sustained monomorphic ventricular tachycardia | Q44446233 | ||
| Effects of chronic amiodarone therapy on defibrillation threshold | Q44817414 | ||
| Motor vehicle accidents in patients with an implantable cardioverter-defibrillator. | Q50114196 | ||
| Driving restrictions advised by midwestern cardiologists implanting cardioverter defibrillators: present practices, criteria utilized, and compatibility with existing state laws | Q67541953 | ||
| A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function | Q67586159 | ||
| Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias | Q68393233 | ||
| Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death | Q71755483 | ||
| A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans | Q72874468 | ||
| Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology | Q74152257 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | syncope | Q180007 |
| defibrillator | Q1450682 | ||
| P304 | page(s) | 608-615 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions | |
| P478 | volume | 31 |
| Q35907154 | Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators:. |
| Q53825607 | Beta-blocker therapy is associated with a lower incidence of syncope due to fast ventricular tachycardias among implantable cardioverter-defibrillator patients with left ventricular dysfunction: results from a multicenter study. |
| Q33168179 | Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial. |
| Q74137320 | Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators |
| Q37695408 | Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators |
| Q47635686 | Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators |
| Q64885251 | Defibrillation efficacy of a subcutaneous array lead: A case report. |
| Q27025928 | Driving and arrhythmia: a review of scientific basis for international guidelines |
| Q42777228 | Driving and arrhythmias |
| Q33159194 | Driving guidelines and restrictions in patients with a history of cardiac arrhythmias, syncope,or implantable devices |
| Q35492836 | Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach |
| Q47149520 | Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers |
| Q33778671 | Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems? |
| Q39828787 | Experiences of Driving and Driving Restrictions in Recipients With an Implantable Cardioverter Defibrillator-The Patient Perspective |
| Q33606164 | Implantable cardioverter-defibrillators |
| Q38668732 | Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing |
| Q40703058 | Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group |
| Q74163334 | Syncope |
| Q79356295 | [Guidelines for the implantation of defibrillators] |
| Q95721097 | [Guidelines of the Spanish Society of Cardiology for car driving, airplane flying,and underwater activities in subjects with heart disease] |
Search more.